|
RNPEP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.28550000000338E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.81369999999426E-05 |
| Normal-vs-Stage2 |
5.377900E-03 |
| Normal-vs-Stage3 |
1.197880E-04 |
| Normal-vs-Stage4 |
1.597840E-04 |
| Stage1-vs-Stage2 |
4.891400E-01 |
| Stage1-vs-Stage3 |
2.523000E-01 |
| Stage1-vs-Stage4 |
1.036990E-01 |
| Stage2-vs-Stage3 |
9.161800E-01 |
| Stage2-vs-Stage4 |
6.371800E-01 |
| Stage3-vs-Stage4 |
6.666200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.90077999999705E-05 |
| Normal-vs-AfricanAmerican |
4.760800E-04 |
| Normal-vs-Asian |
3.340900E-03 |
| Caucasian-vs-AfricanAmerican |
1.797740E-02 |
| Caucasian-vs-Asian |
4.805400E-01 |
| AfricanAmerican-vs-Asian |
1.145740E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.83280000001884E-06 |
| Normal-vs-Female |
1.98256999999202E-05 |
| Male-vs-Female |
1.731430E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.539700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.55504999999057E-05 |
| Normal-vs-Age(61-80Yrs) |
1.77598999999695E-05 |
| Normal-vs-Age(81-100Yrs) |
2.539700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.786000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.200000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.114000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.660990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.481600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.442600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.558800E-01 |
| Classical-VS-Follicular |
8.506200E-01 |
| Classical-VS-Other |
5.336400E-01 |
| Classical-VS-Normal |
1.12850000000275E-06 |
| Tall-VS-Follicular |
5.733000E-01 |
| Tall-VS-Other |
4.151400E-01 |
| Tall-VS-Normal |
5.800600E-03 |
| Follicular-VS-Other |
7.316000E-01 |
| Follicular-VS-Normal |
1.095500E-03 |
| Other-VS-Normal |
7.579900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.09639999999967E-05 |
| Normal-vs-N1 |
7.146000E-02 |
| N0-vs-N1 |
6.562200E-02 |
|
|
